ASX - By Stock
|
PAA |
Re:
Ann: PharmAust raises $10 million via Placement and announces SPP
|
|
Sockit151
|
20 |
6.2K |
2 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
20
|
6.2K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Sockit151
|
159 |
37K |
10 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
37K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
Sockit151
|
206 |
52K |
13 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
206
|
52K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Sockit151
|
85 |
21K |
23 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
21K
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Sockit151
|
601 |
146K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
601
|
146K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Sockit151
|
601 |
146K |
11 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
601
|
146K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Sockit151
|
85 |
21K |
15 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
21K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Pharmaust Investor Update
|
|
Sockit151
|
20 |
5.6K |
8 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
20
|
5.6K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Sockit151
|
1.4K |
365K |
8 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.4K
|
365K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Sockit151
|
1.4K |
365K |
11 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
1.4K
|
365K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
Sockit151
|
250 |
64K |
16 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
250
|
64K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Sockit151
|
83 |
24K |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
83
|
24K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Sockit151
|
66 |
19K |
13 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
66
|
19K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Sockit151
|
55 |
15K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
15K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Sockit151
|
62 |
18K |
11 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
18K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Sockit151
|
100 |
28K |
13 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
28K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Sockit151
|
100 |
28K |
10 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
28K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Sockit151
|
1.4K |
365K |
11 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.4K
|
365K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Sockit151
|
152 |
47K |
7 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
152
|
47K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
$1 party
|
|
Sockit151
|
3 |
1.2K |
9 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
3
|
1.2K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Sockit151
|
1.4K |
365K |
5 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Sockit151
|
1.4K |
365K |
15 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Sockit151
|
1.4K |
365K |
22 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Sockit151
|
197 |
53K |
12 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
197
|
53K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Sockit151
|
1.4K |
365K |
9 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Sockit151
|
323 |
77K |
11 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
323
|
77K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Sockit151
|
323 |
77K |
11 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
323
|
77K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Sockit151
|
323 |
77K |
10 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
323
|
77K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Sockit151
|
430 |
110K |
12 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
430
|
110K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Launches Interactive Investor Hub
|
|
Sockit151
|
16 |
3.4K |
7 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
16
|
3.4K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: New Hires & Attendance at International MND Symposium
|
|
Sockit151
|
56 |
13K |
11 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
56
|
13K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: New Hires & Attendance at International MND Symposium
|
|
Sockit151
|
56 |
13K |
11 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
56
|
13K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Chief Executive Officer Appointment
|
|
Sockit151
|
95 |
23K |
10 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
95
|
23K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Sockit151
|
287 |
79K |
9 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
287
|
79K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
Sockit151
|
200 |
43K |
6 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
200
|
43K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
Sockit151
|
200 |
43K |
20 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
200
|
43K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Sockit151
|
396 |
84K |
3 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
396
|
84K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Louie the Beagle surpasses one year on MPL
|
|
Sockit151
|
37 |
7.7K |
11 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
37
|
7.7K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Sockit151
|
396 |
84K |
9 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
84K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Sockit151
|
147 |
35K |
16 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
147
|
35K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Arrival of additional MPL tablets
|
|
Sockit151
|
25 |
5.8K |
9 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
25
|
5.8K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Stable Patient in MND trial reaches 6-months on MPL
|
|
Sockit151
|
70 |
16K |
7 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
70
|
16K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Stable Patient in MND trial reaches 6-months on MPL
|
|
Sockit151
|
70 |
16K |
7 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
70
|
16K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Stable Patient in MND trial reaches 6-months on MPL
|
|
Sockit151
|
70 |
16K |
8 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
70
|
16K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
MND PK PD data and why it influences the upcoming Covid-19 trial
|
|
Sockit151
|
40 |
9.4K |
12 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
40
|
9.4K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Sockit151
|
164 |
40K |
11 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
164
|
40K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Sockit151
|
164 |
40K |
5 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
164
|
40K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Sockit151
|
164 |
40K |
7 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
164
|
40K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 PAA Option Holders as at 29/12/2020 with only one variation.variations.
|
|
Sockit151
|
64 |
18K |
10 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
64
|
18K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Sockit151
|
44 |
10K |
8 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
44
|
10K
|
8
|
|